James Barry serves as Executive Vice President and President of the Life Science Group at Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of innovative life science research and clinical diagnostic products. In this pivotal role, he oversees the strategic direction, operations, and global commercialization of the group's portfolio, which includes advanced tools for protein research, chromatography, electrophoresis, imaging, and quantitative PCR technologies such as Droplet Digital PCR (ddPCR). Barry's leadership focuses on accelerating scientific discovery by delivering high-performance solutions that enable precise biomolecular analysis for researchers in academia, biopharma, and applied markets worldwide. With over 25 years of experience in the life sciences industry, Barry joined Bio-Rad in 2013 as Vice President of Global Marketing for the Life Science Group, rapidly advancing through roles including Senior Vice President and General Manager. Prior to Bio-Rad, he held senior marketing and strategy positions at Life Technologies (now part of Thermo Fisher Scientific), where he led marketing for the Genetic Analysis Group, and at Agilent Technologies, driving genomics and proteomics initiatives. His expertise spans product development, market expansion, and customer engagement across multinational organizations. Under Barry's stewardship, the Life Science Group has achieved substantial revenue growth, expanded its ddPCR platform into new applications like infectious disease monitoring and oncology research, and strengthened Bio-Rad's position as an innovator in precision biology. His strategic vision has fostered key partnerships, launched breakthrough products, and enhanced operational efficiencies, solidifying Bio-Rad's reputation for reliability and cutting-edge technology in a competitive landscape.